This is a supplement to EyeWorld Magazine.
Issue link: https://supplements.eyeworld.org/i/1462618
14 | 2022 ASCRS Annual Meeting Final Program ASCRS SUBSPECIALTY DAY ASCRS CORNEA DAY 10:27–10:35 a.m. Endothelial keratoplasty in eyes with tube shunts Sophie Deng, MD, PhD 10:36–10:38 a.m. Panel discussion 10:39–10:47 a.m. Point: I prepare EK tissue myself Francis Price, MD 10:51–10:59 a.m. Counterpoint: I use preloaded EK tissue from my eye bank 11:00–11:02 a.m. Panel discussion: Point counterpoint debate 11:03–11:11 a.m. Current state of DSO/DWEK Ula Jurkunas, MD 11:12–11:14 a.m. Panel discussion 11:15–11:23 a.m. Updates in techniques for DALK Nir Sorkin, MD 11:24–11:26 a.m. Panel discussion 11:27–11:35 a.m. Corneal allogenic intrastromal ring segments (CAIRS) Soosan Jacob, MD 11:36–11:40 a.m. Panel discussion/session wrap-up 11:41–11:55 a.m. Government relations Parag Parekh, MD 11: 56 a.m.– Lunch with exhibitors 12:56 p.m. Session III: Ocular Surface Moderators: Karolinne Rocha, MD, PhD, Leela Raju, MD Part 1: Diagnosis and Management of Dry Eye and Co-Conspirators 12:57–1:00 p.m. Welcome back Karolinne Rocha, MD, PhD, Leela Raju, MD 1:00–1:08 p.m. Updates in new mechanisms for dry eye treatment Vishal Jhanji, MD 1:09–1:16 p.m. Latest evidence on lid margin disease management Elizabeth Yeu, MD 1:17–1:24 p.m. Is this dry eye or a co-conspirator? Chris Rapuano, MD 1:25–1:29 p.m. Panel discussion/Q&A 1:30–1:37 p.m. Clinical pearls in the management of neurotrophic keratitis Francis Mah, MD 1:38–1:45 p.m. Is there a role for corneal neurotization? Soroosh Behshad, MD 1:46–1:50 p.m. Panel discussion/Q&A Part 2: Severe Ocular Surface Disease 1:51–1:58 p.m. Treatment approach to severe ocular surface disease Edward J. Holland, MD The following 5 cases are to be shortly presented by the speaker and management approaches discussed with faculty panel: 1:59–2:03 p.m. Case 1: Unilateral non-inflammatory limbal stem cell deficiency case Melissa Daluvoy, MD 2:04–2:08 p.m. Case 1 discussion 2:09–2:13 p.m. Case 2: Acute Stevens-Johnson syndrome case Amy Lin, MD 2:14–2:18 p.m. Case 2 discussion 2:19–2:23 p.m. Case 3: Chronic Stevens-Johnson limbal stem cell deficiency case (Boston KPro vs. limbal stem cell transplant) Anthony Aldave, MD 2:24–2:28 p.m. Case 3 discussion